ChoironeX GalKO Porcine Thymokidney
Phase 1
ChoironeX GalKO Porcine Thymokidney is one of 7 therapeutic programs targeting End-Stage Renal Disease. It is currently in Phase 1.
1
Indications
1
Total Trials
1
Active Trials
6
Competitors
Pipeline
Status by Indication[2][1]
Indication
Competition
Competitive Landscape
7 competitors in End-Stage Renal Disease
#DrugCompanyPhaseTrials
1Prograf
VVeloxis Pharmaceuticals
Approved
Wellbutrin
GSKPreclinical
Apabetalone
RResverlogix Corp
Phase 2
Ribupatide
KKailera
Phase 1
ChoironeX GalKO Porcine Thymokidney
XXeno Holdings (US), LLC dba ChoironeX
Phase 1
Sevelamer Hydrochloride
SanofiPreclinical
Equine Anti-Thymocyte Globulin
NNational Cancer Institute (NCI)
Preclinical
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Expected Milestones
Clinical
Trials by Indication[1]
Sources
References
- [1]
- [2]
- [3]
Details
Drug Info
Quick Facts
- Highest Phase
- Phase 1[1]